We report a case of superficial femoral artery (SFA) stent fractures (SF) with atypical symptoms and site of disruption. Patient was hospitalized for sudden onset of right thigh pain, nonrelated to steno-obstructive disease. Preoperative ultrasound suspected and computed tomographic angiography (CTA) confirmed multiple proximal SFA SFs with concurrent pseudoaneurysms. A peripheral endograft was deployed covering the entire SFA, achieving a complete "relining" with exclusion of the pseudoaneurysm. Pain disappeared and postoperative control demonstrated good patency of the SFA. After 1 month, patient reported no further events and CTA revealed patency of the endograft and exclusion of the pseudoaneurysm. At 1 year follow-up, Viabahn is patent with no further symptoms reported by the patient.
Superficial femoral artery stent disruption treated by peripheral endograft / Sirignano, Pasqualino; Citone, Michele; Menna, Danilo; Mansour, WASSIM AHMAD; Montelione, Nunzio; Capoccia, Laura; Speziale, Francesco. - In: ANNALS OF VASCULAR SURGERY. - ISSN 0890-5096. - STAMPA. - 29:8(2015), pp. 1661-1661.e8. [10.1016/j.avsg.2015.06.085]
Superficial femoral artery stent disruption treated by peripheral endograft
SIRIGNANO, PASQUALINO;CITONE, MICHELE;MENNA, DANILO;MANSOUR, WASSIM AHMAD;MONTELIONE, NUNZIO;CAPOCCIA, LAURA;SPEZIALE, Francesco
2015
Abstract
We report a case of superficial femoral artery (SFA) stent fractures (SF) with atypical symptoms and site of disruption. Patient was hospitalized for sudden onset of right thigh pain, nonrelated to steno-obstructive disease. Preoperative ultrasound suspected and computed tomographic angiography (CTA) confirmed multiple proximal SFA SFs with concurrent pseudoaneurysms. A peripheral endograft was deployed covering the entire SFA, achieving a complete "relining" with exclusion of the pseudoaneurysm. Pain disappeared and postoperative control demonstrated good patency of the SFA. After 1 month, patient reported no further events and CTA revealed patency of the endograft and exclusion of the pseudoaneurysm. At 1 year follow-up, Viabahn is patent with no further symptoms reported by the patient.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
